Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste.

Autor: Chupp G; Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Spichler-Moffarah A; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Søgaard OS; Department of Clinical Medicine and Department of Infectious Diseases, Aarhus University, Aarhus, Denmark., Esserman D; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA., Dziura J; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA., Danzig L; Amicitiam Partners, San Francisco, CA., Chaurasia R; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Patra KP; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Salovey A; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Nunez A; Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT, USA., May J; Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT, USA., Astorino L; Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT, USA., Patel A; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Halene S; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Wang J; Department of Pathology, Yale School of Medicine New Haven, CT, USA., Hui P; Department of Pathology, Yale School of Medicine New Haven, CT, USA., Patel P; Investigation Drug Service, Yale New Haven Hospital, New Haven, CT, USA., Lu J; Investigation Drug Service, Yale New Haven Hospital, New Haven, CT, USA., Li F; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA., Gan G; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA., Parziale S; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA., Katsovich L; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA., Desir GV; Investigation Drug Service, Yale New Haven Hospital, New Haven, CT, USA., Vinetz JM; Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2022 Jan 31. Date of Electronic Publication: 2022 Jan 31.